Fighting bacterial infections FASTer

A cutting-edge test developed by West Australian scientists could be a game changer for the fight against superbugs.
Dr Laura Masters
Dr Laura Masters
Fighting bacterial infections FASTer
Image credit: Getty Images

Antibiotics are powerful drugs used to treat bacterial infections.

Although they have saved countless lives, their overuse has caused drug-resistant superbugs.

Antimicrobial resistance (AMR) occurs when microbes develop resistance to the drugs designed to kill them.

The World Health Organization says AMR is one of the top 10 global public health threats. In 2019, 1.27 million people died from AMR – more than HIV/AIDS or malaria.

But a new test developed by WA scientists could be a game-changer.

fast results

Scientists from the University of Western Australia, PathWest and the Harry Perkins Institute developed the new ‘flow cytometry-assisted antimicrobial susceptibility testing’ (FAST).

The new test is more targeted and accurate than current tests. It’s also a lot faster.

Current tests can take up to five days to identify infecting bacteria and an effective antibiotic to combat it.

FAST can detect a bacterial infection within 30 minutes and the most effective antibiotic treatment in less than five hours.

how does it work?

During a FAST, a flow cytometer machine passes individual bacterium, floating in a suspension, in front of lasers and measures the output with sensitive detectors. It can rapidly analyse hundreds of thousands of individual bacteria cells.

flow cytometer machine | Pacific Northwest National Laboratory via flickr 

Dr Christine Carson is a Senior Research Fellow at UWA who co-authored the study.

She says the test offers “a tremendous amount of detail” when exposing bacteria to antibiotic drugs.

“We can see signatures, different patterns of changes in the [bacterial] populations that we get, depending on which drug has been used,” says Christine.

According to her, the test has potential applications beyond the diagnostic lab.


Part of a global effort to combat AMR is a focus on identifying new antimicrobial drugs.

The amount of detail obtained from FAST will enable drug researchers to screen candidate drugs in new ways – opening new doors in the fight against bacterial infections.

The testing method can rapidly screen hundreds of novel compounds and identify those that are effective at killing even the most drug-resistant bacteria.

Flow cytometry-assisted antimicrobial susceptibility testing offers speed and precision for our battle against superbugs.

When it comes to antibiotics, Christine says the key question is “how do you assess antimicrobial susceptibility?”

Dr Laura Masters
About the author
Dr Laura Masters
Laura is research microbiologist with an interest in viruses, particularly those that are important in pregnancy and early life. She's always been fascinated by science, and willing to share her passion with anyone who will listen.
View articles
Laura is research microbiologist with an interest in viruses, particularly those that are important in pregnancy and early life. She's always been fascinated by science, and willing to share her passion with anyone who will listen.
View articles


We've got chemistry, let's take it to the next level!

Get the latest WA science news delivered to your inbox, every fortnight.


Creative Commons Logo

Republishing our content

We want our stories to be shared and seen by as many people as possible.

Therefore, unless it says otherwise, copyright on the stories on Particle belongs to Scitech and they are published under a Creative Commons Attribution-NoDerivatives 4.0 International License.

This allows you to republish our articles online or in print for free. You just need to credit us and link to us, and you can’t edit our material or sell it separately.

Using the ‘republish’ button on our website is the easiest way to meet our guidelines.


You cannot edit the article.

When republishing, you have to credit our authors, ideally in the byline. You have to credit Particle with a link back to the original publication on Particle.

If you’re republishing online, you must use our pageview counter, link to us and include links from our story. Our page view counter is a small pixel-ping (invisible to the eye) that allows us to know when our content is republished. It’s a condition of our guidelines that you include our counter. If you use the ‘republish’ then you’ll capture our page counter.

If you’re republishing in print, please email us to let us so we know about it (we get very proud to see our work republished) and you must include the Particle logo next to the credits. Download logo here.

If you wish to republish all our stories, please contact us directly to discuss this opportunity.


Most of the images used on Particle are copyright of the photographer who made them.

It is your responsibility to confirm that you’re licensed to republish images in our articles.


All Particle videos can be accessed through YouTube under the Standard YouTube Licence.

The Standard YouTube licence

  1. This licence is ‘All Rights Reserved’, granting provisions for YouTube to display the content, and YouTube’s visitors to stream the content. This means that the content may be streamed from YouTube but specifically forbids downloading, adaptation, and redistribution, except where otherwise licensed. When uploading your content to YouTube it will automatically use the Standard YouTube licence. You can check this by clicking on Advanced Settings and looking at the dropdown box ‘License and rights ownership’.
  2. When a user is uploading a video he has license options that he can choose from. The first option is “standard YouTube License” which means that you grant the broadcasting rights to YouTube. This essentially means that your video can only be accessed from YouTube for watching purpose and cannot be reproduced or distributed in any other form without your consent.


For more information about using our content, email us:

Copy this HTML into your CMS
Press Ctrl+C to copy